Filing Flows › Carlsmed (CARL) › Q1 2026 › vs Q4 2025
Carlsmed (CARL) Q1 2026 vs Q4 2025 (quarter over quarter)
Carlsmed's revenue rose $951K (+6%) from $15.2M in Q4 2025 to $16.1M in Q1 2026.
Carlsmed, Q1 2026: revenue $16.1M (+58% year over year), operating margin -57.6%, net loss $8.7M, operating cash flow −$13.0M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $16.1M | $15.2M | $951K | +6% |
| Other income, net | $580K | $705K | −$125K | -18% |
| Net loss | $8.7M | $8.6M | $83K | +1% |
| Costs & expenses | $25.4M | $24.5M | $909K | +4% |
| Operating costs | $25.4M | $24.5M | $909K | +4% |
| Cost of revenue | $3.7M | $3.6M | $134K | +4% |
| Research & development | $5.2M | $5.3M | −$86K | -2% |
| Sales & marketing | $10.3M | $10.8M | −$512K | -5% |
| General & admin | $6.2M | $4.9M | $1.4M | +28% |
| Operating cash sources | $14.7M | $6.2M | $8.5M | +137% |
| Depreciation & amortization | $99K | $98K | $1K | +1% |
| Share-based compensation | $1.6M | $790K | $839K | +106% |
| Cash used in operations | $13.0M | $5.3M | $7.7M | +144% |
| Net loss absorbed | $8.7M | $8.6M | $83K | +1% |
| Working capital & other | $6.0M | −$2.4M | $8.4M | — |
Questions
How much did Carlsmed's revenue grow quarter over quarter in Q1 2026?
Carlsmed's revenue rose $951K (+6%) from $15.2M in Q4 2025 to $16.1M in Q1 2026.